Potential Implications of the REFINE Trial on the Myelofibrosis Treatment Paradigm

Naveen Pemmaraju, MD, talks about the potential implications of the phase II REFINE trial on the myelofibrosis treatment paradigm.

EP: 1.An Overview of Myelofibrosis

EP: 2.The Role of Biomarker Testing in Patients with Myelofibrosis

EP: 3.Current Treatment Options in Myelofibrosis

EP: 4.Study Design and Outcomes of the Phase II REFINE Trial

Now Viewing

EP: 5.Potential Implications of the REFINE Trial on the Myelofibrosis Treatment Paradigm

EP: 6.Investigational Agents and Unmet Needs in Myelofibrosis Treatment

Recent Videos